Fleury SA
BOVESPA:FLRY3

Watchlist Manager
Fleury SA Logo
Fleury SA
BOVESPA:FLRY3
Watchlist
Price: 13.89 BRL -0.5% Market Closed
Market Cap: 7.6B BRL
Have any thoughts about
Fleury SA?
Write Note

Intrinsic Value

The intrinsic value of one FLRY3 stock under the Base Case scenario is 19.4 BRL. Compared to the current market price of 13.89 BRL, Fleury SA is Undervalued by 28%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

FLRY3 Intrinsic Value
19.4 BRL
Undervaluation 28%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Fleury SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for FLRY3 cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about FLRY3?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Fleury SA

Provide an overview of the primary business activities
of Fleury SA.

What unique competitive advantages
does Fleury SA hold over its rivals?

What risks and challenges
does Fleury SA face in the near future?

Summarize the latest earnings call
of Fleury SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Fleury SA.

Provide P/S
for Fleury SA.

Provide P/E
for Fleury SA.

Provide P/OCF
for Fleury SA.

Provide P/FCFE
for Fleury SA.

Provide P/B
for Fleury SA.

Provide EV/S
for Fleury SA.

Provide EV/GP
for Fleury SA.

Provide EV/EBITDA
for Fleury SA.

Provide EV/EBIT
for Fleury SA.

Provide EV/OCF
for Fleury SA.

Provide EV/FCFF
for Fleury SA.

Provide EV/IC
for Fleury SA.

Show me price targets
for Fleury SA made by professional analysts.

What are the Revenue projections
for Fleury SA?

How accurate were the past Revenue estimates
for Fleury SA?

What are the Net Income projections
for Fleury SA?

How accurate were the past Net Income estimates
for Fleury SA?

What are the EPS projections
for Fleury SA?

How accurate were the past EPS estimates
for Fleury SA?

What are the EBIT projections
for Fleury SA?

How accurate were the past EBIT estimates
for Fleury SA?

Compare the revenue forecasts
for Fleury SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Fleury SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Fleury SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Fleury SA compared to its peers.

Compare the P/E ratios
of Fleury SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Fleury SA with its peers.

Analyze the financial leverage
of Fleury SA compared to its main competitors.

Show all profitability ratios
for Fleury SA.

Provide ROE
for Fleury SA.

Provide ROA
for Fleury SA.

Provide ROIC
for Fleury SA.

Provide ROCE
for Fleury SA.

Provide Gross Margin
for Fleury SA.

Provide Operating Margin
for Fleury SA.

Provide Net Margin
for Fleury SA.

Provide FCF Margin
for Fleury SA.

Show all solvency ratios
for Fleury SA.

Provide D/E Ratio
for Fleury SA.

Provide D/A Ratio
for Fleury SA.

Provide Interest Coverage Ratio
for Fleury SA.

Provide Altman Z-Score Ratio
for Fleury SA.

Provide Quick Ratio
for Fleury SA.

Provide Current Ratio
for Fleury SA.

Provide Cash Ratio
for Fleury SA.

What is the historical Revenue growth
over the last 5 years for Fleury SA?

What is the historical Net Income growth
over the last 5 years for Fleury SA?

What is the current Free Cash Flow
of Fleury SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Fleury SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Fleury SA

Current Assets 4.2B
Cash & Short-Term Investments 2B
Receivables 1.9B
Other Current Assets 219.4m
Non-Current Assets 8.6B
Long-Term Investments 216.3m
PP&E 2.5B
Intangibles 5.8B
Other Non-Current Assets 112.8m
Current Liabilities 1.8B
Accounts Payable 676.5m
Accrued Liabilities 428.8m
Other Current Liabilities 669.4m
Non-Current Liabilities 5.7B
Long-Term Debt 4.6B
Other Non-Current Liabilities 1.1B
Efficiency

Earnings Waterfall
Fleury SA

Revenue
7.5B BRL
Cost of Revenue
-5.4B BRL
Gross Profit
2.1B BRL
Operating Expenses
-899.7m BRL
Operating Income
1.2B BRL
Other Expenses
-564m BRL
Net Income
597m BRL

Free Cash Flow Analysis
Fleury SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

FLRY3 Profitability Score
Profitability Due Diligence

Fleury SA's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional 1-Year Revenue Growth
58/100
Profitability
Score

Fleury SA's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

FLRY3 Solvency Score
Solvency Due Diligence

Fleury SA's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Positive Net Debt
44/100
Solvency
Score

Fleury SA's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

FLRY3 Price Targets Summary
Fleury SA

Wall Street analysts forecast FLRY3 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FLRY3 is 19.7 BRL with a low forecast of 16.16 BRL and a high forecast of 25.2 BRL.

Lowest
Price Target
16.16 BRL
16% Upside
Average
Price Target
19.7 BRL
42% Upside
Highest
Price Target
25.2 BRL
81% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for FLRY3?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for FLRY3 is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Fleury SA Logo
Fleury SA

Country

Brazil

Industry

Health Care

Market Cap

7.6B BRL

Dividend Yield

5.4%

Description

Fleury SA engaged in the provision of medical diagnostic services. The company is headquartered in Sao Paulo, Sao Paulo and currently employs 20,800 full-time employees. The company went IPO on 2009-12-16. The Company’s activities are divided into three business lines: Patient Service Centers (PSC), B2B and Dental Diagnosis. The PCS division offers private medical diagnostics. The B2B division is responsible for clinical analysis and diagnostic imaging in partner hospitals, as well as tests for laboratories, hospitals and clinics throughout Brazil. The Dental Diagnosis division provides dental diagnostic imaging through Papaiz Associados Diagnosticos por Imagem SA, a joint venture with Odontoprev SA. The firm operates through several brands, such as Fleury Medicina e Saude, Clinica Felippe Mattoso e Weinmann, a+ Medicina Diagnostica, Diagnoson a+, Diagmax and Inlab, among others.

Contact

SAO PAULO
Sao Paulo
Av. General Valdomiro de Lima, 508, Jabaquara
+551150351986
www.fleury.com.br

IPO

2009-12-16

Employees

20 800

Officers

CEO & President of Executive Board
Ms. Jeane Mike Tsutsui
CFO, Investor Relations Officer & Member of Executive Board
Mr. Jose Antonio de Almeida Filippo
Executive Director of New Links & Member of Executive Board
Mr. Claudio Almeida Prado
Medical, Technical & Process Executive Director and Member of Executive Board
Mr. Edgar Gil Rizzatti
L2L & Operations Support Officer and Member of Executive Board
Mr. Roberto Santoro Meirelles
Secretary
Mr. Fernando Aguiar Camargo

See Also

Discover More
What is the Intrinsic Value of one FLRY3 stock?

The intrinsic value of one FLRY3 stock under the Base Case scenario is 19.4 BRL.

Is FLRY3 stock undervalued or overvalued?

Compared to the current market price of 13.89 BRL, Fleury SA is Undervalued by 28%.

Back to Top